144 related articles for article (PubMed ID: 37333273)
41. STING agonist inflames the cervical cancer immune microenvironment and overcomes anti-PD-1 therapy resistance.
Li T; Zhang W; Niu M; Wu Y; Deng X; Zhou J
Front Immunol; 2024; 15():1342647. PubMed ID: 38550593
[TBL] [Abstract][Full Text] [Related]
42. Discovery of Pyrido[2,3-
Sun Y; Chen M; Han Y; Li W; Ma X; Shi Z; Zhou Y; Xu L; Yu L; Wang Y; Yu J; Diao X; Meng L; Xu S
J Med Chem; 2024 Mar; 67(5):3986-4006. PubMed ID: 38387074
[TBL] [Abstract][Full Text] [Related]
43. Development of a High-Throughput Assay to Identify Inhibitors of ENPP1.
Kumar M; Lowery RG
SLAS Discov; 2021 Jun; 26(5):740-746. PubMed ID: 33402044
[TBL] [Abstract][Full Text] [Related]
44. CD38 restrains the activity of extracellular cGAMP in a model of multiple myeloma.
Cuollo L; Di Cristofano S; Sandomenico A; Iaccarino E; Oliver A; Zingoni A; Cippitelli M; Fionda C; Petillo S; Kosta A; Tassinari V; Petrucci MT; Fazio F; Ruvo M; Santoni A; Raimondo D; Soriani A
iScience; 2024 May; 27(5):109814. PubMed ID: 38746669
[TBL] [Abstract][Full Text] [Related]
45. Discovery of VH domains that allosterically inhibit ENPP1.
Solomon PE; Bracken CJ; Carozza JA; Wang H; Young EP; Wellner A; Liu CC; Sweet-Cordero EA; Li L; Wells JA
Nat Chem Biol; 2024 Jan; 20(1):30-41. PubMed ID: 37400538
[TBL] [Abstract][Full Text] [Related]
46. A 2D Nanoradiosensitizer Enhances Radiotherapy and Delivers STING Agonists to Potentiate Cancer Immunotherapy.
Luo T; Nash GT; Jiang X; Feng X; Mao J; Liu J; Juloori A; Pearson AT; Lin W
Adv Mater; 2022 Sep; 34(39):e2110588. PubMed ID: 35952624
[TBL] [Abstract][Full Text] [Related]
47. The analog of cGAMP, c-di-AMP, activates STING mediated cell death pathway in estrogen-receptor negative breast cancer cells.
Vasiyani H; Shinde A; Roy M; Mane M; Singh K; Singh J; Gohel D; Currim F; Vaidya K; Chhabria M; Singh R
Apoptosis; 2021 Jun; 26(5-6):293-306. PubMed ID: 33840002
[TBL] [Abstract][Full Text] [Related]
48. cGAMP the travelling messenger.
Blest HTW; Chauveau L
Front Immunol; 2023; 14():1150705. PubMed ID: 37287967
[TBL] [Abstract][Full Text] [Related]
49. STING agonist cGAMP enhances anti-tumor activity of CAR-NK cells against pancreatic cancer.
Da Y; Liu Y; Hu Y; Liu W; Ma J; Lu N; Zhang C; Zhang C
Oncoimmunology; 2022; 11(1):2054105. PubMed ID: 35371622
[TBL] [Abstract][Full Text] [Related]
50. Hepatitis C Virus NS4B Can Suppress STING Accumulation To Evade Innate Immune Responses.
Yi G; Wen Y; Shu C; Han Q; Konan KV; Li P; Kao CC
J Virol; 2016 Jan; 90(1):254-65. PubMed ID: 26468527
[TBL] [Abstract][Full Text] [Related]
51. [1,2,4]Triazolo[1,5-a]pyrimidine derivatives: Structure-activity relationship study leading to highly selective ENPP1 inhibitors.
Kawaguchi M; Minami S; Ieda N; Nakagawa H
Bioorg Med Chem Lett; 2024 Jun; ():129820. PubMed ID: 38851358
[TBL] [Abstract][Full Text] [Related]
52. Antitumor Activity of cGAMP via Stimulation of cGAS-cGAMP-STING-IRF3 Mediated Innate Immune Response.
Li T; Cheng H; Yuan H; Xu Q; Shu C; Zhang Y; Xu P; Tan J; Rui Y; Li P; Tan X
Sci Rep; 2016 Jan; 6():19049. PubMed ID: 26754564
[TBL] [Abstract][Full Text] [Related]
53. Development of an ENPP1 Fluorescence Probe for Inhibitor Screening, Cellular Imaging, and Prognostic Assessment of Malignant Breast Cancer.
Kawaguchi M; Han X; Hisada T; Nishikawa S; Kano K; Ieda N; Aoki J; Toyama T; Nakagawa H
J Med Chem; 2019 Oct; 62(20):9254-9269. PubMed ID: 31536342
[TBL] [Abstract][Full Text] [Related]
54. Assessing the cGAS-cGAMP-STING Activity of Cancer Cells.
Pépin G; Gantier MP
Methods Mol Biol; 2018; 1725():257-266. PubMed ID: 29322423
[TBL] [Abstract][Full Text] [Related]
55. Small molecules targeting the innate immune cGAS‒STING‒TBK1 signaling pathway.
Ding C; Song Z; Shen A; Chen T; Zhang A
Acta Pharm Sin B; 2020 Dec; 10(12):2272-2298. PubMed ID: 33354501
[TBL] [Abstract][Full Text] [Related]
56. Selective STING stimulation in dendritic cells primes antitumor T cell responses.
Jneid B; Bochnakian A; Hoffmann C; Delisle F; Djacoto E; Sirven P; Denizeau J; Sedlik C; Gerber-Ferder Y; Fiore F; Akyol R; Brousse C; Kramer R; Walters I; Carlioz S; Salmon H; Malissen B; Dalod M; Piaggio E; Manel N
Sci Immunol; 2023 Jan; 8(79):eabn6612. PubMed ID: 36638189
[TBL] [Abstract][Full Text] [Related]
57. Cell-to-cell communications of cGAS-STING pathway in tumor immune microenvironment.
Wang M; Xu P; Wu Q
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 53(1):15-24. PubMed ID: 38229499
[TBL] [Abstract][Full Text] [Related]
58.
He Y; Hong C; Irvine DJ; Li J; Hammond PT
Bio Protoc; 2021 Feb; 11(3):e3905. PubMed ID: 33732792
[TBL] [Abstract][Full Text] [Related]
59. Self-assembled cGAMP-STINGΔTM signaling complex as a bioinspired platform for cGAMP delivery.
He Y; Hong C; Yan EZ; Fletcher SJ; Zhu G; Yang M; Li Y; Sun X; Irvine DJ; Li J; Hammond PT
Sci Adv; 2020 Jun; 6(24):eaba7589. PubMed ID: 32582856
[TBL] [Abstract][Full Text] [Related]
60. Zebularine elevates STING expression and enhances cGAMP cancer immunotherapy in mice.
Lai J; Fu Y; Tian S; Huang S; Luo X; Lin L; Zhang X; Wang H; Lin Z; Zhao H; Lin S; Zhao J; Xu S; Li D; Cai S; Dong L; Qian J; Liang J; Li Q; Zhang Y; Fan J; Balderas R; Chen Q
Mol Ther; 2021 May; 29(5):1758-1771. PubMed ID: 33571681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
